Fulgent Genetics Inc
FLGT
Get informed when a big investor buys or sells
+ FollowMarket Cap$565.17M
Close$
$7.42
62.2% downside
Current Fair Value
62.2% downsideOvervalued by 62.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $565.17 Million |
|---|---|
| Enterprise Value | $678.73 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.97 |
| Beta | 0.91 |
| Outstanding Shares | 28,005,000 |
Return
| Return on Equity | -8.42% |
|---|---|
| Return on Assets | -7.75% |
| Return on Invested Capital | -9.99% |
Valuation & Multiples
| P/E Ratio | -7.06 |
|---|---|
| PEG | -12.65 |
| Price to Sales | 1.78 |
| Price to Book Ratio | 0.56 |
| Enterprise Value to Revenue | 2.1 |
| Enterprise Value to EBIT | -6.68 |
| Enterprise Value to Net Income | -9 |
| Total Debt to Enterprise | 0.21 |
| Debt to Equity | 0.14 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 7, 2026
EPS Estimate
$-0.26
Average shareholder expectationRevenue Estimate
$89.95 M
Average shareholder expectationNext Earnings Call
Expected Date
November 6, 2026
EPS Estimate
$-0.65
Average shareholder expectationRevenue Estimate
$86.30 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.1126▼ 30.28% |
|---|---|
| Total Calls | 116,300▲ 90.97% |
| Total Puts | 13,100▼ 48.22% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 51.97%▼ 4.73% |
|---|---|
| Total Invested | $329.40M▲ 18.72% |
| Investors Holding | 147▼ 14.00% |
ESG Score
No data
About Fulgent Genetics Inc
429 employees
CEO: Ming Hsieh Fulgent Genetics' proprietary technology platform has created a broad, flexible test menu and the ability to continually expand and improve its proprietary genetic reference library while maintaining accessible pricing, high accuracy and...